West Pharmaceutical(WST) - 2024 Q4 - Earnings Call Presentation
Fourth Quarter Overall Net Sales 1.78 Adjusted Diluted Earnings Per Share: $1.82 "I am pleased to report we had a strong quarter with revenues and profits exceeding our expectations, and a return to positive organic growth as the impact of destocking continues to moderate. Our core businesses continue to benefit from our market-leading positions and proprietary processes. Looking ahead to 2025, we expect our business momentum to continue in key areas of our Propri ...